Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
NCT04990739
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
MTB-9655
Sponsor
MetaboMed Inc